{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fpce.simplecast.com%2Fepisodes%2Fadvanced-urothelial-cancer-part-2-I7v93Jrg","width":444,"version":"1.0","type":"rich","title":"Advanced Urothelial Cancer: Applying New Therapeutic Options, Part 2","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/86952976-b928-4317-884c-2c7ba3b2ae4d/1db1e725-7613-4c5a-a737-f61fa4b2daea/pce-podcast-urothelial-cancer-part2-3000x3000.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/cd823f9c-fe10-4c38-9cae-1a6e551c10a1\" height=\"200\" width=\"100%\" title=\"Advanced Urothelial Cancer: Applying New Therapeutic Options, Part 2\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"In this episode, Arjun Balar, MD discusses the management of adverse events in patients with advanced urothelial cancer being treated by novel therapies and is joined by Rana McKay, MD and moderator Terran Sims, MSN to review patient cases and provide answer pressing questions from the audience. Claim your credit at pce.is/GIGU."}